Search
for
Sort by
Research 151–180 of 230
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Involvement of ILC1-like innate lymphocytes in human autoimmunity, lessons from alopecia areata
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics
- Assessment of Cytokine-Mediated Signaling Pathway Dysregulation in Arm Skin After CO2 Laser Therapy
- Cell death in skin function, inflammation, and disease
- Alopecia areata – Current understanding and management
- Evaluating the Metabolomic Profile and Anti-Pathogenic Properties of Cannabis Species
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Mechanisms of autophagy and their implications in dermatological disorders
- Baricitinib for the Treatment of Alopecia Areata
- Immune therapies for alopecia areata: evidence and new perspectives
- Pathophysiology of Alopecia Areata in the Pediatric Patient
- Genetic Variants and Protective Immunity against SARS-CoV-2
- Efficacy and Potential Mechanisms of Naringin in Atopic Dermatitis
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- From bedside to bench: regulation of host factors in SARS-CoV-2 infection
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Molecular mediators involved in skin healing: a narrative review
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- Identifying barriers and disparities in the healthcare of patients with alopecia areata: a mixed-methods analysis using claims data and qualitative interview data
- JAK inhibition decreases the autoimmune burden in Down syndrome
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice